ClinicalTrials.gov
ClinicalTrials.gov Menu

Peer Coaching for Low-Income Patients With Diabetes in Primary Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01040806
Recruitment Status : Completed
First Posted : December 30, 2009
Last Update Posted : December 13, 2011
Sponsor:
Collaborator:
American Academy of Family Physicians
Information provided by (Responsible Party):
Thomas Bodenheimer, University of California, San Francisco

Brief Summary:
Patients with diabetes who are counseled by a peer coach (another patient with diabetes) will have improved glycemic control compared with usual care patients.

Condition or disease Intervention/treatment Phase
Diabetes Type 2 Behavioral: Usual care Behavioral: Health coaching Not Applicable

Detailed Description:
Peer coaches have controlled diabetes, patient study subjects have poorly controlled diabetes.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Peer Coaching for Low-Income Patients With Diabetes in Primary Care
Study Start Date : August 2009
Actual Primary Completion Date : May 2011
Actual Study Completion Date : May 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Health coaching
Patients with poorly controlled diabetes will receive counseling from a peer health coach -- a patient with diabetes trained in health coaching
Behavioral: Health coaching
Peer health coaches will counsel patients with diabetes
Other Names:
  • Peer coaching
  • Peer coach
  • Peer support
Active Comparator: Usual care
Patients will receive usual care
Behavioral: Usual care
Patients will receive their usual medical care



Primary Outcome Measures :
  1. HbA1c level [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. LDL cholesterol level [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diabetes with most recent HbA1c 8 or above in past 6 months.

Exclusion Criteria:

  • Dementia,
  • Life expectancy less than 6 months,
  • Inability to speak English or Spanish.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01040806


Locations
United States, California
San Francisco General Hospital
San Francisco, California, United States, 94110
Sponsors and Collaborators
University of California, San Francisco
American Academy of Family Physicians
Investigators
Principal Investigator: Thomas Bodenheimer, MD University of California, San Francisco

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thomas Bodenheimer, Adjunct Professor of Family and Community Medicine, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT01040806     History of Changes
Other Study ID Numbers: H40013-34104-01
First Posted: December 30, 2009    Key Record Dates
Last Update Posted: December 13, 2011
Last Verified: December 2011

Keywords provided by Thomas Bodenheimer, University of California, San Francisco:
Diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases